PHARMAC - Latest News [Page 1]
Pharmac Expands Access To Funded Cancer Medicines For Adolescents And Young Adults
Wednesday, 30 September 2026, 2:18 pm | PHARMAC
“From 14 October, this access will be extended to adolescents and young adults with paediatric-origin cancers who meet the eligibility criteria,” says Pharmac's Chief Medical Officer, Dr David Hughes. More >>
Pharmac Opens Recruitment For New Community And Patient Advisory Committee
Wednesday, 23 September 2026, 4:13 pm | PHARMAC
Dr Ngawati says CPAC’s establishment reflects feedback from patient and consumer groups, including members of the interim advisory committee. More >>
Pharmac Proposal To Improve Access To Medicines For People With High Blood Pressure And Bacterial Infections
Tuesday, 15 September 2026, 2:18 pm | PHARMAC
MacGibbon says the proposal has been informed by clinical advice and feedback from healthcare professionals. More >>
Flu Vaccine Now Funded For All Children Under Five As Influenza Cases Rise
Tuesday, 1 September 2026, 12:53 pm | PHARMAC
Geraldine MacGibbon, Pharmac’s Director, Pharmaceuticals, says the agencies have been watching influenza activity closely and acted quickly in response. More >>
Pharmac Makes Access To Estradiol TDP Mylan (Oestradiol) Patches Easier For New Zealanders
Wednesday, 12 August 2026, 11:18 am | PHARMAC
From 1 September 2026, people will be able to collect up to three months’ supply of Estradiol TDP Mylan patches from their pharmacy at a time, rather than the previous one month’s supply. More >>
More People To Access Cholesterol-Lowering Medicine
Wednesday, 5 August 2026, 11:26 am | PHARMAC
Widened access to diabetes medicines to benefit over 30,000 New Zealanders More >>
Pharmac To Refresh Patient Advisory Function
Monday, 3 August 2026, 12:56 pm | PHARMAC
“These changes mean we can hear from people earlier and more often, so their experiences will shape our work from the start,” says Pharmac Chair Paula Bennett. More >>
More People To Access Cholesterol-Lowering Medicine
Tuesday, 30 June 2026, 11:07 am | PHARMAC
Rosuvastatin tablets will be available without restrictions from 1 October 2026. This means people will no longer need to meet specific eligibility criteria to access the medicine. More >>
Pharmac Funds Another ADHD Medicine To Improve Supply
Wednesday, 24 June 2026, 11:08 am | PHARMAC
“This decision builds on the steps we’ve already taken to improve supply, including funding lisdexamfetamine in late 2024 and Methylphenidate Sandoz XR in late 2025.” More >>
Pharmac To Fund Medicines Used By Ambulance Providers
Tuesday, 9 June 2026, 11:28 am | PHARMAC
From 1 July 2026, Pharmac will fund medicines used by ambulance services, following a Government decision to transfer this responsibility from Health New Zealand and ACC. More >>
More New Zealanders Could Benefit From Funded Vaccines From 2027
Thursday, 21 May 2026, 3:03 pm | PHARMAC
Pharmac’s Director Pharmaceuticals, Adrienne Martin, says if the proposal is approved, around 260,000 children would be eligible for a funded flu vaccine for the first time. More >>
Pharmac To Fund Two New Combination Treatments
Thursday, 14 May 2026, 2:41 pm | PHARMAC
If approved, the changes would apply to new applications from 1 August 2026 onwards. People who are already receiving these medicines would continue to have access and would not notice any change. More >>
Public Hospitals To Save Millions On Drug-Eluting Stents
Thursday, 14 May 2026, 12:36 pm | PHARMAC
There will be a transition period from 1 June 2026 to 30 September 2026 to allow public hospitals to undertake any required training and education and change over to the new stock of drug-eluting stents. More >>
Pharmac To Fund Two New Combination Treatments, And Widen Access To Another, For People With A Type Of Blood Cancer
Thursday, 9 April 2026, 11:35 am | PHARMAC
The decision follows consultation with people with CLL, their families, clinicians, and consumer advocacy groups. More >>
Pharmac Funds Medicine To Reduce Complications Following Allogenic Haematopoietic Stem Cell Transplant
Wednesday, 8 April 2026, 2:40 pm | PHARMAC
The medicine will be funded for use in hospitals and through community pharmacies. Around 90 people are expected to benefit in the first full year of funding. More >>
Pharmac Invites Feedback Before Possible Medicine Brand Changes
Wednesday, 8 April 2026, 11:27 am | PHARMAC
No decisions have been made about whether any medicine brands will change. Feedback from the consultation will be considered alongside clinical and technical advice before any decisions are made. More >>
Pharmac Widens Access To Two Melanoma Medicines
Tuesday, 7 April 2026, 11:37 am | PHARMAC
Clinical advice provided to Pharmac shows that these treatments can reduce the risk of melanoma coming back. More >>
Pharmac Proposal To Procure Drug-Eluting Stents Will Mean Savings For Public Hospitals
Thursday, 26 March 2026, 2:05 pm | PHARMAC
The proposed deal would award Principal Supply Status for permanent coronary drug-eluting stents for public hospitals to Medtronic New Zealand. Hospitals would be able to invest the proposed savings into new and emerging technologies. More >>
Pharmac Seeks Feedback To Make Access To Medicines Clearer & Simpler For People With Exceptional Clinical Circumstances
Tuesday, 17 March 2026, 11:21 am | PHARMAC
The Framework is used when a person’s clinical situation is unusual or complex and existing funded medicines or standard funding rules are not suitable. More >>
Pharmac Widening Access To A Treatment For People With A Rare Blood Cancer
Thursday, 12 March 2026, 1:52 pm | PHARMAC
This change comes after Pharmac consulted on a proposal for brentuximab vedotin to be used as a first-line treatment option in people newly diagnosed with sALCL. More >>
